Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

查看全文 作　　者：Yung-Jue;Bang;Young-Woo;Kim;Han-Kwang;Yang;Hyun;Cheol;Chung;Young-Kyu;Park;Kyung;Hee;Lee;Keun-Wook;Lee;Yong;Ho;Kim;Sang-Ik;Noh;Jae;Yong;Cho;Young;Jae;Mok;Yeul;Hong;Kim;Jiafu;Ji;Ta-Sen;Yeh;Peter;Button;Florin;Sirzén;Sung;Hoon;Noh 出　　处：《The Lancet》索引2012年第9813期,共0页